News: 2 Arthritis Drugs Reduce Deaths in... (The New York Times) - Behind the headlines
In the news
Media coverage of health and science topics
2 Arthritis Drugs Reduce Deaths in Very Ill Covid Patients, Study Finds
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.
Read more at The New York Times
Behind the headlines
Research findings and data from the National Library of Medicine
PubMed articles
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
In hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation, tocilizumab reduced the likelihood of progression to the composite outcome …
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
In this randomized clinical trial of hospitalized adult patients with COVID-19 pneumonia and Pao2/Fio2 ratio between 200 and 300 mm Hg who received tocilizumab, no benefi …
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial
In this randomized clinical trial of patients with COVID-19 and pneumonia requiring oxygen support but not admitted to the intensive care unit, TCZ did not reduce WHO-CPS …
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19. Some benefit or harm cannot be ruled out, however, …
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the fi …
Related content
Similar articles
Reviews
People also viewed
Also of interest
Additional recent and related news
An Explanation for Some Covid-19 Deaths May Not Be Holding Up
Recent studies have created doubts about an agent in cytokine storms, and suggest that treatments for it may not help.
New results from a once-promising therapy show the difficulty of treating covid-19
The drug, tocilizumab, showed early potential but evidence since then has been conflicting.
Inexpensive Steroids Can Save Lives Of Seriously Ill COVID-19 Patients
Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.
Steroids can save lives of patients with severe covid-19, earning WHO endorsement
New studies confirm British findings and replicate them with multiple steroids.
Hydroxychloroquine doesn’t benefit hospitalized COVID-19 patients
In a final analysis of study data, researchers concluded that the medication hydroxychloroquine provides no benefit to adults hospitalized with COVID-19.